These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21535150)

  • 1. Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention.
    Hanna N; Fiorilli P; Gaglia MA; Torguson R; Vita A; Ben-Dor I; Xue Z; Waksman R; Bernardo NL
    J Interv Cardiol; 2011 Jun; 24(3):278-84. PubMed ID: 21535150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is heparin reversal required for the safe performance of percutaneous endovascular aortic aneurysm repair?
    Jabori S; Jimenez JC; Gabriel V; Quinones-Baldrich WJ; Derubertis BG; Farley S; Gelabert HA; Rigberg DA
    Ann Vasc Surg; 2013 Nov; 27(8):1049-53. PubMed ID: 24011808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regarding protamine, ACT and sheath removal.
    Walker S
    J Interv Cardiol; 2012 Jun; 25(3):313-4. PubMed ID: 22487202
    [No Abstract]   [Full Text] [Related]  

  • 4. Immediate protamine administration and sheath removal following percutaneous coronary intervention: a prospective study of 429 patients.
    Ducas J; Chan MC; Miller A; Kashour T
    Catheter Cardiovasc Interv; 2002 Jun; 56(2):196-9. PubMed ID: 12112912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of the StarClose device for obtaining femoral artery hemostasis.
    Rodriguez A; Katz SG
    Vasc Endovascular Surg; 2011 Oct; 45(7):627-30. PubMed ID: 21646232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of complications following sheath removal with percutaneous coronary intervention.
    Sulzbach-Hoke LM; Ratcliffe SJ; Kimmel SE; Kolansky DM; Polomano R
    J Cardiovasc Nurs; 2010; 25(3):E1-8. PubMed ID: 20357666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin reversal with protamine sulfate is not required in atrial fibrillation ablation with suture hemostasis.
    Yasar SJ; Bickel T; Zhang S; Akkaya M; Aznaurov SG; Krishnan K; Cuculich PS; Gautam S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2811-2817. PubMed ID: 31661173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR.
    Al-Kassou B; Kandt J; Lohde L; Shamekhi J; Sedaghat A; Tabata N; Weber M; Sugiura A; Fimmers R; Werner N; Grube E; Treede H; Nickenig G; Sinning JM
    JACC Cardiovasc Interv; 2020 Jun; 13(12):1471-1480. PubMed ID: 32553337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
    Guo Y; Tang J; Du L; Liu J; Liu RC; Liu X; Guo Y
    Can J Cardiol; 2012; 28(5):547-52. PubMed ID: 22633184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy outcomes of protamine administration for heparin reversal following cryoballoon-based pulmonary vein isolation.
    Gurses KM; Kocyigit D; Yalcin MU; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Oto MA; Ozer N; Aytemir K
    J Interv Card Electrophysiol; 2015 Aug; 43(2):161-7. PubMed ID: 25724721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of closure strategies after balloon aortic valvuloplasty: suture mediated versus collagen based versus manual.
    Ben-Dor I; Looser P; Bernardo N; Maluenda G; Torguson R; Xue Z; Lindsay J; Pichard AD; Satler LF; Waksman R
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):119-24. PubMed ID: 21681898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Totally percutaneous thoracic endovascular aortic repair with the preclosing technique: a case-control study.
    Ni ZH; Luo JF; Huang WH; Liu Y; Xue L; Fan RX; Chen JY
    Chin Med J (Engl); 2011 Mar; 124(6):851-5. PubMed ID: 21518591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine sulfate use during tibial bypass does not appear to increase thrombotic events or affect short-term graft patency.
    Phair J; Futchko J; Trestman EB; Carnevale M; Friedmann P; Shukla H; Garg K; Koleilat I
    Vascular; 2020 Dec; 28(6):708-714. PubMed ID: 32393108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients.
    Eggebrecht H; Haude M; Woertgen U; Schmermund A; von Birgelen C; Naber C; Baumgart D; Kaiser C; Oldenburg O; Bartel T; Kroeger K; Erbel R
    Catheter Cardiovasc Interv; 2002 Dec; 57(4):486-95. PubMed ID: 12455083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a novel procedure sheath and closure device during diagnostic catheterization: the multicenter randomized clinical trial of the FISH device.
    Bavry AA; Raymond RE; Bhatt DL; Chambers CE; DeNardo AJ; Hermiller JB; Myers PR; Pitts DE; Scott JA; Savader SJ; Steinhubl S
    J Invasive Cardiol; 2008 Apr; 20(4):152-6. PubMed ID: 18398227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation.
    Rossi ML; Zavalloni D; Scatturin M; Gasparini GL; Lisignoli V; Presbitero P
    Expert Opin Pharmacother; 2007 Sep; 8(13):2017-24. PubMed ID: 17714056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter randomized trial comparing a percutaneous collagen hemostasis device with conventional manual compression after diagnostic angiography and angioplasty.
    Sanborn TA; Gibbs HH; Brinker JA; Knopf WD; Kosinksi EJ; Roubin GS
    J Invasive Cardiol; 1999 Sep; 11 Suppl B():6B-13B. PubMed ID: 10745611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of a percutaneous suture-mediated closure system after 6 - 8F transfemoral approaches: results for 2200 patients].
    Kamusella P; Wissgott C; Andresen R
    Rofo; 2012 Apr; 184(4):311-5. PubMed ID: 22274872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extravascular closure for patients with high-risk femoral anatomy.
    Rashid MN; Ahmed B; Straight F; Bradley JT; Gilbert K; Gogo PB; Terrien EF; Watkins MW; Dauerman HL
    J Invasive Cardiol; 2008 Jul; 20(7):328-32. PubMed ID: 18599888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.